Generic Semaglutide in Canada 2026: SEVMIA, Obeda & GLP-1 Nutrition Guide

As of June 2026, generic semaglutide is approved in Canada under several brand names: SEVMIA, Obeda (Dr. Reddy’s), and Apotex. This approval dramatically increases access to GLP-1 treatment for Canadians struggling with obesity. Whether you’re taking Ozempic, Wegovy, or now a generic semaglutide, here’s what you need to know about nutrition to maximize your results. […]